# Cipla USA Inc.

Canonical: https://abierto.us/vendors/cipla-usa-inc-q2mkmcp1cdt7

- UEI: Q2MKMCP1CDT7
- CAGE: 7WV84
- Location: Warren, NJ
- Awards in window: 2 (19 transactions), $0 obligated, February 2, 2024 to July 15, 2026

## Awarding agencies

- Department of Veterans Affairs: 2 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 36E79721D0016: $0, Nac Pharmaceuticals. Exercise Option Year 3, Effective April 1, 2024 to March 31, 2025 for Ambrisentan Tablets with Cipla Usa, INC.. https://www.usaspending.gov/award/CONT_IDV_36E79721D0016_3600/
- 36F79721D0092: $0, Nac Federal Supply Schedule. Voluntary TPR. https://www.usaspending.gov/award/CONT_IDV_36F79721D0092_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/cipla-usa-inc-q2mkmcp1cdt7.